MedPath

Hemodynamic Effects of Ventilation Modes

Conditions
Respiration, Artificial
Laparoscopy
Hemodynamics
Interventions
Procedure: Mode of Mechanical Ventilation
Registration Number
NCT03684291
Lead Sponsor
Ufuk University
Brief Summary

Different ventilation modes can be used in laparoscopic surgeries. These surgeries are performed in steep Trendelenburg position with serious hemodynamic disturbances. This study aims to observe the hemodynamic effects of two different ventilation modes in laparoscopic gynecologic surgery performed in steep Trendelenburg position.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Women of ASA I and II classification between 18-65 years scheduled for elective gynecologic laparoscopic surgery
Exclusion Criteria
  • Patient refusal to participate
  • Patients with severe cardiac (congestive heart failure etc) and pulmonary (COPD, pulmonary hypertension) disease (ASA > III)
  • Morbid obesity
  • Negative Allen test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group VMode of Mechanical VentilationThe patients in this group are ventilated using VCV (Volume Control Ventilation) mode (FiO2 50%, Tidal volume: 6-8 ml/kg (ideal body weight), frequency: 12/minute, I/E ratio: 1/2, PEEP not applied)
Group PMode of Mechanical VentilationThe patients in this group are ventilated using PCV-VG (Volume Guaranteed Pressure Control Ventilation) mode (FiO2 50%, Tidal volume: 6-8 ml/kg (ideal body weight), frequency: 12/minute (EtCO2 kept between 35-40 mmHg), Pressure limit: 30 cm H2O, I/E:1/2, PEEP not applied)
Primary Outcome Measures
NameTimeMethod
Measurement of changes in MAPT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Mean arterial pressure (MAP) (mmHg)

Measurement of changes in heart rateT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Heart rate (bpm)

Measurement of changes in systemic vascular resistance indexT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Systemic vascular resistance index (dyne x sec/cm2)

Measurement of changes in stroke volume indexT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Stroke volume index (mL/m2)

Measurement of changes in cardiac indexT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Cardiac index L(min x m2)

Measurement of changes in stroke volume variationT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Stroke volume variation (%)

Measurement of changes in cardiac cycle efficiencyT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Cardiac cycle efficiency (units)

Measurement of changes in aortic dp/dtT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Aortic dP/dt (mmHg/msec)

Secondary Outcome Measures
NameTimeMethod
Measurement of changes in peak airway pressureT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Ppeak (Peak airway pressure)

Measurement of changes in mean airway pressureT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Pmean (Mean Airway Pressure),

Measurement of changes in plateau airway pressureT0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation

Pplateau (Plateau Airway Pressure)

Trial Locations

Locations (1)

Ufuk University Faculty of Medicine

🇹🇷

Ankara, Balgat, Turkey

© Copyright 2025. All Rights Reserved by MedPath